Neuromyelitis optica spectrum disorders (NMOSD) are a group of autoimmune conditions 20 characterized by inflammatory involvement of the optic nerve, spinal cord (typically 21 longitudinally extensive transverse myelitis, or LETM) and the supratentorial central nervous 22
system. The disease typically affects young adults, but improved diagnostic testing with specific 23 autoantibodies against aquaporin 4 (AQP4) has led to increasing rates of diagnosis in older 24 populations. 25 26 Late-Onset NMOSD (LONMOSD) is usually defined as onset > 50 years of age, and it is 27 thought to be more severe than early-onset EONMOSD 2 . Furthermore, brainstem involvement 28 and area postrema syndrome (APS) are exceedingly rare in LONMOSD. We present the case of 29 a 68-year-old woman who presented with APS and AQP4+ LONMOSD. 30
31
A 68-year-old woman presented to the ER with 4 days of nausea, vomiting and intractable 32 hiccups. Work-up for metabolic and infectious causes and a brain CT were negative, and she was 33 referred to the GI unit for an upper-endoscopy that revealed antral gastritis (H. Pylori negative). 34
She was treated with proton pump inhibitors and sucralfate. After 3-weeks there was no 35 improvement and she developed left arm and leg weakness and presented back to the ER. 36 37 On exam, she was alert and cranial nerves were normal (including funduscopy). She had left 38 sided weakness (4/5) in the upper extremity and in the hip flexors; tone was normal and reflexes 39 were brisk (3+) in the left with up-going toes. Sensory exam was normal, her gait was unsteady, 40 and she had a positive Romberg test. She denied any recent travel, fevers, or night sweats. 41
Routine laboratory workup was normal, including ANA and acute phase reactants. An MRI of 42 the brain and spine revealed multiple non-specific white matter hyperintensities, subtle changes 43 and enhancement surrounding the 4 th ventricle, and an enhancing, longitudinally extensive (C5-44 T1), left lateral cervical cord lesion ( Figure 1 ). CSF testing was bland with a normal protein and 45 only 5 WBCs. An infectious panel was negative, including HSV I and II, VZV, and enterovirus. 46
Serum AQP4-antibody was high-positive (cell-based assay) and anti-MOG antibodies were 47 negative. 48 49 NMOSD was diagnosed and she was started on 1g of IV methylprednisolone. After 5 doses she 50 showed no improvement, and she was transitioned to plasmapheresis (PLEX). After 5 sessions 51 (every other day), her weakness improved and her brainstem symptoms resolved. She was 52 treated with prednisone 50 mg/day and was started on rituximab for maintenance therapy. 53 54 APS occurs when there is involvement of the AP, a chemosensitive region of the brainstem 55 known to be the "vomiting center" of the brain 1 , and strongly suggests NMOSD. Patients with 56 LONMOSD have an age-dependent higher incidence of systemic comorbidities. Coupled with 57 the misconception that NMOSD is a disorder exclusive of the young, atypical presentations 58 might go undiagnosed. Intractable vomiting and hiccups are likely to be attributed to a primary 59 gastrointestinal disorder, and even imaging suggestive of LETM may be interpreted as 60 suggestive of a neoplasm. Our patient presented with these symptoms and only after she 61 developed signs of a myelopathy was the diagnosis of NMOSD entertained. 62 63 LONMOSD may have a more severe phenotype. In one of the earliest series of patients with 64 LONMOSD, the characteristics of 45 people were reviewed 2 . LONMOSD was seen 65 predominantly in women (80%) and rapid accumulation of disability as well as a high mortality 66 rate was noted. Another series of 30 cases of LONMOSD in a Chinese population found a 67 median age of onset of 57.5 years (86.7% were women) and also confirmed a higher degree of 68 disability 3 . Neither of these 2 cohorts reported APS as a presenting symptom. In the most recent 69 series of 69 people with LONMOSD, presentation was not different from EONMOSD, but older 70 age at onset did predict worse functional outcome (particularly in AQP4 positive patients) 4 . Only 71 6 of these patients had a brainstem syndrome, but it is unclear if any these presented with APS, 72
suggesting that brainstem involvement and APS are rare in this subpopulation. 73
74
In another recent Chinese cohort of 59 people with LONMOSD, it was noted that lesions around 75 the 4th ventricle were less common when compared with EONMOSD 5 . They did, however, 76 report 12 clinical events of APS. A Korean cohort of 45 patients with LONMOSD also 77 confirmed that brainstem lesions adjacent to the fourth ventricle and periependymal lesions 78
surrounding the lateral ventricles were less frequently observed when compared with 79 EONMOSD (3 vs 28 lesions) 6 . 80 81
Around 15-30% of NMOSD are considered LONMOSD at presentation, with a median age of 82 onset between 50 and 60 years 2-6 . "Very-Late NMOSD", variably defined as with an onset >65 83 or 70 years of age is rarer still. In the Chinese cohort described by Zhang et al. 5 Acute management in LONMOSD does not differ from EONMOSD. Our patient responded 91 poorly to steroids, but PLEX led to quick arrest of her worsening and after 5 cycles there was 92 objective improvement. Use of long term immunotherapy has been described to be less frequent 93 in LONMSD 4 , but authors agree that early aggressive management is warranted considering the 94 poor outcome and rapidly accumulating disability 6 . Azathioprine and mycophenolate-mofetil are 95 usually employed 6 , but some series suggest that this subpopulation exhibits more frequent 96 tolerability issues as well as opportunistic infectious complications 2,7 . In our patient, plans were 97 made for long term immunomodulation with rituximab. 98 MRI revealed a 45mm hyperintense lesion in C5-T1 (C, large arrow). The lesion showed subtle 131 enhancement (insert, arrowhead). There was enhancement around the periaqueductal posterior 132 medulla (D). 133
